Form 4 for HCA HCA Healthcare
Accepted 2022-01-03 00:00:00 ET · period of report 2021-12-29 · accession 0001209191-22-000339 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-03 | 2021-12-29 | HCA | Sowell Joseph A III | SVP, Chief Development Off | F - Tax | $258.49 | -20.6K | 34.6K | -37% | -$5.31M |
| D | 2022-01-03 | 2021-12-29 | HCA | Sowell Joseph A III | SVP, Chief Development Off | M - OptEx | $37.18 | +42.8K | 55.1K | +346% | +$1.59M |
| D | 2022-01-03 | 2021-12-29 | HCA | Sowell Joseph A III | SVP, Chief Development Off | M - OptEx | $0.00 | -42.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-29 | F | D | 20,552 | $258.49 | 34,555 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-29 | M | A | 42,750 | $37.18 | 55,107 | D | — | — | |
| 3 | Derivative | Stock Appreciation Right | 2021-12-29 | M | D | 42,750 | $0.00 | 0 | D | $37.18 · — to 2023-02-06 | 42,750 Common Stock | (F2) The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. |